Stage FocusSeed, Series A, Series B+
GeographyEurope
TypeVC
Last Activity2025
Industry Focus
Industries
AIBlockchainSpaceCybersecuritySemiconductorsHardware
Technical BenchLimited
Investor TypeGeneralist
ExposureSome DeepTech Investments
Bio
XAnge was founded in 2003 as part of the Siparex Group and became B Corp certified in 2023. The firm manages €650-700M across 200+ portfolio companies, with the XAnge 5 fund (€200M first close, November 2025) expanding the pan-European early-stage mandate. Check sizes run €1-10M from seed to Series B.
Four investment themes drive the portfolio: Application Software, Deep Tech Software (AI and cyb...
Notable Investments
L
LedgerA
AerospacelabSimilar Funds
Bessemer Venture Partners
Menlo Park, United States
GeneralistAISpaceClimate TechSeedSeries A
Colle Capital
New York, United States
GeneralistAIMedtechIoT & EdgeSeedSeries A
LG Technology Ventures
Seoul, South Korea
GeneralistAIAdvanced MaterialsMedtechSeedSeries A
Northzone
London, United Kingdom
GeneralistAISemiconductorsRoboticsSeedSeries A
Sequoia Capital
Menlo Park, United States
GeneralistAISpaceRoboticsSeedSeries A
Balderton Capital
London, United Kingdom
GeneralistAIMobilityMedtechSeedSeries A